Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques

Our previous work has shown that antigens adjuvanted with ligands specific for Toll-like receptor 4 (TLR4) and TLR7/8 encapsulated in poly(lactic-co-glycolic) acid (PLGA)-based nanoparticles (NPs) induce robust and durable immune responses in mice and macaques. We investigated the efficacy of these...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Virol
Main Authors: Kasturi, Sudhir Pai, Kozlowski, Pamela A., Nakaya, Helder I., Burger, Matheus C., Russo, Pedro, Pham, Mathew, Kovalenkov, Yevgeniy, Silveira, Eduardo L. V., Havenar-Daughton, Colin, Burton, Samantha L., Kilgore, Katie M., Johnson, Mathew J., Nabi, Rafiq, Legere, Traci, Sher, Zarpheen Jinnah, Chen, Xuemin, Amara, Rama R., Hunter, Eric, Bosinger, Steven E., Spearman, Paul, Crotty, Shane, Villinger, Francois, Derdeyn, Cynthia A., Wrammert, Jens, Pulendran, Bali
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2017
נושאים:
Vaccines and Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286877/
https://ncbi.nlm.nih.gov/pubmed/27928002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01844-16
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים